IPO

Search documents
X @mert | helius.dev
mert | helius.dev· 2025-07-31 20:12
so basicallyfigma IPO priced at ~$30 by private bankers where you get allo based on fees you pay to the underwritersthe actual market opens at 95, and goes past 120 — meaning figma missed out on ~3B and retail got rinsedso basically this is MEV with suits ...
Figma Shares Jump 242% in Trading Debut After $1.2 Billion IPO
Bloomberg Television· 2025-07-31 19:52
I mean, wow. Two triple. No wonder price discovery took so long and it took forever to get this opening trade.But really, the retail investment enthusiasm, institutional investor enthusiasm has been phenomenal. This was 40 times oversubscribed. IPO people wanted it that much.And remember, they actually went out there and sort of auctioned this on the roadshow, trying to get a better price discovery than perhaps we've seen for Circle All for Cool Wave. But the pop has still been more than tripling of that $3 ...
Figma and Backers Raise $1.2B in IPO
Bloomberg Technology· 2025-07-31 19:43
Kleiner Perkins history with Dylan Field, the CEO goes way back. And I'm just interested as to your perspective of what you saw in him in that series. BROWN Yeah.So we've been fortunate partners with Taylor Fields for the last eight years or so, and Dylan always embodies the spirit of what we embody. Kleiner Perkins We want to back founders who make history. And Dylan is certainly one of those.And we actually look back at our investment memo from 2017. We wrote something like Dylan and Evan are special foun ...
Figma IPO portends more IPOs but speaks to speculative market fervor: Craig Moffett
CNBC Television· 2025-07-31 19:10
They didn't. We got Craig Moffett. We've got Steve Kovak with us as well.Craig Moffett, as an analyst, I'm going to kind of ask you the same question that I just asked Mike Sani. I know you don't cover the company. I'm not asking you to comment on the earnings or anything like that, but does this IPO mean anything to macro tech in what has been just a bonkers, in a good way, market for big tech the last couple years.>> Uh, well, sure. I I guess there's there's two ways to look at it though, right. I mean, o ...
独角兽IPO加速 多家企业冲刺“火箭第一股”
Shen Zhen Shang Bao· 2025-07-31 19:05
【深圳商报讯】(记者周良成)近日,独角兽企业IPO热度上升。中国证监会官网显示,蓝箭航天空间 科技股份有限公司7月29日在北京证监局进行了辅导备案,正式启动科创板IPO征程,有望成为"火箭第 一股",其辅导机构为中金公司。 目前有多家民营商业航天企业正在竞争"火箭第一股"。记者梳理发现,2020年12月,北京星际荣耀空间 科技股份有限公司上市辅导备案;2022年3月,长光卫星启动上市辅导备案;今年6月,天津爱思达航天 科技股份有限公司上市辅导备案等。 备案报告显示,蓝箭航天是一家北京的独角兽企业,成立日期为2015年6月1日,注册资本3.6亿元。蓝 箭航天是国内最早成立的民商火箭企业之一。2023年7月,蓝箭航天完成全球首款液氧甲烷运载火箭朱 雀二号遥二成功入轨。公开资料显示,截至2024年底,蓝箭航天累计融资超70亿元,投资方包括国家制 造业转型升级基金、红杉资本中国基金等。 据悉,独角兽企业是指成立10年以内、估值超过10亿美元、获得过私募投资且尚未上市的企业。根据 《2025GEI中国独角兽企业研究报告》,中国独角兽企业数量最多的城市"前三甲"为北京、上海、深 圳,数量分别为75家、59家、42家。 记 ...
Backblaze Continues Growth But Operating Losses Weigh
Seeking Alpha· 2025-07-31 18:40
Group 1 - The article discusses the services provided by IPO Edge, which includes actionable information on growth stocks, first-look IPO filings, previews on upcoming IPOs, an IPO calendar, a database of U.S. IPOs, and a comprehensive guide to IPO investing [1]
X @TechCrunch
TechCrunch· 2025-07-31 18:17
Figma's stock soars in its highly anticipated IPO, market cap instantly hits $45B | TechCrunch https://t.co/xnLwsR5GjG ...
X @Anthony Pompliano 🌪
Anthony Pompliano 🌪· 2025-07-31 16:32
Figma's stock price increasing 3x on IPO day is just another sign of retail being at a disadvantage.Billions of dollars quietly transferred from employees who built the company to investors who will flip out of the stock in a few days. ...
上市公司动态 | 中国石化预计上半年净利同比降39.5%至43.7%,泰诺麦博科创板IPO获受理,德力佳主板IPO过会
He Xun Cai Jing· 2025-07-31 16:20
(原标题:上市公司动态 | 中国石化预计上半年净利同比降39.5%至43.7%,泰诺麦博科创板IPO获受 理,德力佳主板IPO过会) 重点要闻 中国石化预计上半年净利润为人民币201亿元—216亿元 中国石化(600028)披露2025年半年度业绩预告。根据披露,预计2025年上半年实现归属于母公司股东 的净利润为人民币201亿元至人民币216亿元,与上年同期相比,将下降39.5%至43.7%。2025年上半年 实现归属于母公司股东的扣除非经常性损益后的净利润为人民币200亿元至人民币215亿元,与上年同期 相比,将下降39.6%至43.8%。 公司称,业绩变动的主要原因为2025 年上半年,面对严峻复杂的经营形势,公司加大生产经营优化力 度,从严从紧控制成本费用。但受国际原油价格大幅下跌、石油石化市场竞争激烈、化工市场毛利低迷 等因素影响,上半年归属于母公司股东的净利润同比下降。 IPO发行动态 泰诺麦博科创板IPO获受理 珠海泰诺麦博制药股份有限公司科创板IPO获上交所受理。根据披露,公司是一家面向全球市场、致力 于血液制品替代疗法的创新生物制药企业。已成功开发出全球同类首创(First-in-Class ...